National Health Act 1953 Amendment determination under section 85B price determinations and special patient contributions (No. PB 23 of 2009) (Cth)

COMMONWEALTH OF AUSTRALIA

Instrument number PB 23 of 2009

Amendment determination under section 85B of the National Health Act 1953

I, DIANA MACDONELL, Acting Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this instrument under section 85B of the National Health Act 1953.

Dated           3rd March   2009

DIANA MACDONELL

Acting Assistant Secretary

Pharmaceutical Evaluation Branch

Department of Health and Ageing

Amendment — price determinations and special patient contributions

1              Commencement  

This instrument commences on 1 April 2009.

2              Amendment of PB 118 of 2008

Schedule 1 amends PB 118 of 2008.

Schedule 1        Amendments

[1]         Schedule 1, item dealing with Alprazolam in the form Tablet 250 micrograms

omit from the column headed “Claimed Price”:

3.43

and substitute:

3.63

[2]           Schedule 1, item dealing with Alprazolam in the form Tablet 500 micrograms

omit from the column headed “Claimed Price”:

5.16

and substitute:

5.37

[3]           Schedule 1, item dealing with Alprazolam in the form Tablet 1 mg

omit from the column headed “Claimed Price”:

8.56

and substitute:

8.81

[4]           Schedule 1, item dealing with Alprazolam in the form Tablet 2 mg

omit from the column headed “Claimed Price”:

12.95

and substitute:

13.25

[5]           Schedule 1, item dealing with Amlodipine in the form Tablet 5 mg (as besylate)

omit from the column headed “Claimed Price”:

11.76

and substitute:

12.50

[6]           Schedule 1, item dealing with Amlodipine in the form Tablet 10 mg (as besylate)

omit from the column headed “Claimed Price”:

19.88

and substitute:

20.95

[7]           Schedule 1, omit item dealing with Azathioprine

[8]           Schedule 1, item dealing with Betaxolol

(a) omit from the column headed “Determined Price”:

7.05

and substitute:

7.71

(b) omit from the column headed “Claimed Price”:

8.78

and substitute:

9.61

[9]           Schedule 1, item dealing with Brinzolamide

(a) omit from the column headed “Determined Price”:

13.29

and substitute:

15.11

(b) omit from the column headed “Claimed Price”:

14.18

and substitute:

16.18

[10]         Schedule 1, omit item dealing with Carbomer 980 and substitute

Carbomer Eye gel 2 mg per g, 10 g Application to the eye Viscotears 1 3.56 4.43

[11]         Schedule 1, item dealing with Ciprofloxacin in the form Eye drops 3 mg (as hydrochloride) per mL, 5 mL

(a) omit from the column headed “Determined Price”:

8.66

and substitute:

10.09

(b) omit from the column headed “Claimed Price”:

9.46

and substitute:

10.98

[12]         Schedule 1, item dealing with Clindamycin

(a) omit from the column headed “Determined Price”:

11.60

and substitute:

12.32

(b) omit from the column headed “Claimed Price”:

12.86

and substitute:

13.58

[13]         Schedule 1, item dealing with Dexamethasone with Framycetin and Gramicidin

(a) omit from the column headed “Determined Price”:

2.04

and substitute:

2.73

(b) omit from the column headed “Claimed Price”:

3.78

and substitute:

4.47

[14]         Schedule 1, item dealing with Enalapril in the form Tablet containing enalapril maleate 5 mg

omit from the column headed “Claimed Price”:

7.98

and substitute:

9.58

[15]         Schedule 1, item dealing with Enalapril in the form Tablet containing enalapril maleate 10 mg (Renitec)

omit from the column headed “Claimed Price”:

11.73

and substitute:

13.33

[16]         Schedule 1, item dealing with Enalapril in the form Tablet containing enalapril maleate 20 mg (Renitec 20)

omit from the column headed “Claimed Price”:

14.36

and substitute:

15.95

[17]         Schedule 1, item dealing with Erythromycin in the form Tablet 400 mg (as ethyl succinate)

(a) omit from the column headed “Determined Price”:

2.56

and substitute:

3.91

(b) omit from the column headed “Claimed Price”:

4.61

and substitute:

6.35

[18]         Schedule 1, item dealing with Erythromycin in the form Powder for oral liquid 200 mg (as ethyl succinate)

per 5 mL, 100 mL

(a) omit from the column headed “Determined Price”:

2.16

and substitute:

2.93

(b) omit from the column headed “Claimed Price”:

3.61

and substitute:

5.42

[19]         Schedule 1, item dealing with Erythromycin in the form Powder for oral liquid 400 mg (as ethyl succinate)

per 5 mL, 100 mL

(a) omit from the column headed “Determined Price”:

3.23

and substitute:

3.87

(b) omit from the column headed “Claimed Price”:

4.40

and substitute:

6.38

[20]         Schedule 1, item dealing with Escitalopram

omit from the columns in the order indicated:

Oral solution 10 mg (as oxalate) per mL, 28 mL Oral Lexapro 1 27.54 31.47

[21]         Schedule 1, after item dealing with Frusemide

insert in the columns in the order indicated:

Gabapentin Capsule 100 mg Capsule 300 mg Capsule 400 mg Tablet 600 mg Tablet 800 mg Oral Oral Oral Oral Oral Neurontin Neurontin Neurontin Neurontin Neurontin 100 100 100 100 100 15.12 50.54 68.93 109.41 145.85 15.99 51.44 69.84 110.32 146.76

[22]         Schedule 1, item dealing with Gemfibrozil

omit from the column headed “Claimed Price”:

22.25

and substitute:

22.81

[23]         Schedule 1, item dealing with Hypromellose with Dextran

(a) omit from the column headed “Determined Price”:

3.56

and substitute:

3.75

(b) omit from the column headed “Claimed Price”:

5.01

and substitute:

5.37

[24]         Schedule 1, item dealing with Levonorgestrel with Ethinyloestradiol in the form Tablets

150 micrograms-30 micrograms, 21

omit from the column headed “Claimed Price”:

19.73

and substitute:

20.81

[25]         Schedule 1, item dealing with Levonorgestrel with Ethinyloestradiol in the form Pack containing 21 tablets

150 micrograms-30 micrograms and 7 inert tablets (Microgynon 30 ED)

omit from the column headed “Claimed Price”:

19.73

and substitute:

20.81

[26]         Schedule 1, item dealing with Levonorgestrel with Ethinyloestradiol in the form Pack containing 21 tablets

150 micrograms-30 micrograms and 7 inert tablets (Nordette 28)

omit from the column headed “Claimed Price”:

20.02

and substitute:

20.43

[27]         Schedule 1, item dealing with Levonorgestrel with Ethinyloestradiol in the form Pack containing 6 tablets

50 micrograms-30 micrograms, 5 tablets 75 micrograms-40 micrograms, 10 tablets 125 micrograms-

30 micrograms and 7 inert tablets (Triquilar ED)

omit from the column headed “Claimed Price”:

19.73

and substitute:

20.81

[28]         Schedule 1, item dealing with Levonorgestrel with Ethinyloestradiol in the form Pack containing 6 tablets

50 micrograms-30 micrograms, 5 tablets 75 micrograms-40 micrograms, 10 tablets 125 micrograms-

30 micrograms and 7 inert tablets (Triphasil 28)

omit from the column headed “Claimed Price”:

20.02

and substitute:

20.43

[29]         Schedule 1, item dealing with Lisinopril in the form Tablet 5 mg (Prinivil 5)

omit from the column headed “Claimed Price”:

8.03

and substitute:

9.62

[30]         Schedule 1, item dealing with Lisinopril in the form Tablet 10 mg (Prinivil 10)

omit from the column headed “Claimed Price”:

11.39

and substitute:

12.97

[31]         Schedule 1, item dealing with Lisinopril in the form Tablet 20 mg (Prinivil 20)

omit from the column headed “Claimed Price”:

14.00

and substitute:

15.58

[32]         Schedule 1, item dealing with Metformin in the form Tablet containing metformin hydrochloride 500 mg (Diabex)

omit from the column headed “Claimed Price”:

7.02

and substitute:

7.36

[33]         Schedule 1, item dealing with Metformin in the form Tablet containing metformin hydrochloride 850 mg

(Diabex 850)

omit from the column headed “Claimed Price”:

7.02

and substitute:

7.36

[34]         Schedule 1, item dealing with Metformin in the form Tablet containing metformin hydrochloride 1 g

omit from the column headed “Claimed Price”:

11.33

and substitute:

11.67

[35]         Schedule 1, omit item dealing with Methylphenidate

[36]         Schedule 1, item dealing with Methylprednisolone

(a) omit from the column headed “Determined Price”:

15.99

and substitute:

16.46

(b) omit from the column headed “Claimed Price”:

16.65

and substitute:

17.12

[37]         Schedule 1, item dealing with Metoclopramide

(a) omit from the column headed “Determined Price”:

1.41

and substitute:

1.55

(b) omit from the column headed “Claimed Price”:

4.03

and substitute:

4.17

[38]         Schedule 1, item dealing with Paraffin in the form Eye ointment, compound, containing white soft paraffin with liquid paraffin, 3.5 g

(a) omit from the column headed “Determined Price”:

6.56

and substitute:

6.84

(b) omit from the column headed “Claimed Price”:

7.45

and substitute:

7.82

[39]         Schedule 1, omit items dealing with Pilocarpine

[40]         Schedule 1, item dealing with Piroxicam in the form Dispersible tablet 10 mg

omit from the column headed “Claimed Price”:

7.10

and substitute:

7.60

[41]         Schedule 1, item dealing with Piroxicam in the form Dispersible tablet 20 mg

omit from the column headed “Claimed Price”:

6.83

and substitute:

7.32

[42]         Schedule 1, item dealing with Piroxicam in the form Capsule 10 mg

omit from the column headed “Claimed Price”:

7.10

and substitute:

7.60

[43]         Schedule 1, item dealing with Piroxicam in the form Capsule 20 mg

omit from the column headed “Claimed Price”:

6.83

and substitute:

7.32

[44]         Schedule 1, item dealing with Prazosin in the form Tablet 1 mg (as hydrochloride)

omit from the column headed “Claimed Price”:

7.40

and substitute:

7.96

[45]         Schedule 1, item dealing with Prazosin in the form Tablet 2 mg (as hydrochloride)

omit from the column headed “Claimed Price”:

9.47

and substitute:

10.04

[46]         Schedule 1, item dealing with Prazosin in the form Tablet 5 mg (as hydrochloride)

omit from the column headed “Claimed Price”:

14.79

and substitute:

15.41

[47]         Schedule 1, item dealing with Quinapril in the form Tablet 5 mg (as hydrochloride)

omit from the column headed “Claimed Price”:

7.08

and substitute:

7.17

[48]         Schedule 1, item dealing with Quinapril in the form Tablet 10 mg (as hydrochloride)

omit from the column headed “Claimed Price”:

10.03

and substitute:

10.15

[49]         Schedule 1, item dealing with Quinapril in the form Tablet 20 mg (as hydrochloride)

omit from the column headed “Claimed Price”:

12.51

and substitute:

12.70

[50]         Schedule 1, item dealing with Sertraline in the form Tablet 50 mg (as hydrochloride)

omit from the column headed “Claimed Price”:

16.22

and substitute:

17.16

[51]         Schedule 1, item dealing with Sertraline in the form Tablet 100 mg (as hydrochloride)

omit from the column headed “Claimed Price”:

16.22

and substitute:

17.16

[52]         Schedule 1, item dealing with Simvastatin in the form Tablet 5 mg

omit from the column headed “Claimed Price”:

12.65

and substitute:

14.28

[53]         Schedule 1, item dealing with Simvastatin in the form Tablet 10 mg

omit from the column headed “Claimed Price” (twice occurring):

17.13

and substitute:

18.76

[54]         Schedule 1, item dealing with Simvastatin in the form Tablet 20 mg

omit from the column headed “Claimed Price” (twice occurring):

24.23

and substitute:

25.85

[55]         Schedule 1, item dealing with Simvastatin in the form Tablet 40 mg

omit from the column headed “Claimed Price” (twice occurring):

34.46

and substitute:

36.48

[56]         Schedule 1, item dealing with Simvastatin in the form Tablet 80 mg

omit from the column headed “Claimed Price” (twice occurring):

49.13

and substitute:

50.86

[57]         Schedule 1, item dealing with Spironolactone in the form Tablet 25 mg

omit from the column headed “Claimed Price”:

6.53

and substitute:

6.88

[58]         Schedule 1, item dealing with Spironolactone in the form Tablet 100 mg

omit from the column headed “Claimed Price”:

22.51

and substitute:

22.98

[59]         Schedule 1, item dealing with Sulfasalazine

omit from the column headed “Claimed Price”:

23.73

and substitute:

23.74

[60]         Schedule 1, item dealing with Timolol in the form Eye drops 2.5 mg (as maleate) per mL, 5 mL

omit from the column headed “Claimed Price”:

5.70

and substitute:

7.24

[61]         Schedule 1, item dealing with Timolol in the form Eye drops 5 mg (as maleate) per mL, 5 mL

omit from the column headed “Claimed Price”:

6.41

and substitute:

7.96

[62]         Schedule 1, item dealing with Tinidazole

(a) omit from the column headed “Determined Price”:

2.42

and substitute:

2.55

(b) omit from the column headed “Claimed Price”:

4.60

and substitute:

4.73

[63]         Schedule 2, omit item dealing with Escitalopram